Use your antibodies-online credentials, if available.
Keine Produkte auf Ihrer Vergleichsliste.
Ihr Warenkorb ist leer.
Alle Spezies anzeigen
Weitere Synonyme anzeigen
Wählen Sie die Spezies und Applikation aus
anti-Rat (Rattus) Antikörper:
anti-Mouse (Murine) Antikörper:
Sie gelangen zu unserer vorgefilterten Suche.
Human Monoclonal GLN1 Primary Antibody für BI, IF - ABIN968015
Fei, DAmbrosio, Li, Surmacz, Baserga: Association of insulin receptor substrate 1 with simian virus 40 large T antigen. in Molecular and cellular biology 1995
Show all 5 Pubmed References
Human Monoclonal GLN1 Primary Antibody für BI, IF - ABIN968014
Kronfeld, Kazimirsky, Lorenzo, Garfield, Blumberg, Brodie: Phosphorylation of protein kinase Cdelta on distinct tyrosine residues regulates specific cellular functions. in The Journal of biological chemistry 2000
Show all 5 Pubmed References
Human Polyclonal GLN1 Primary Antibody für IHC, IHC (p) - ABIN4314692
Ko, Lin, Flomenberg, Pestell, Howell, Sotgia, Lisanti, Martinez-Outschoorn: Glutamine fuels a vicious cycle of autophagy in the tumor stroma and oxidative mitochondrial metabolism in epithelial cancer cells: implications for preventing chemotherapy resistance. in Cancer biology & therapy 2012
Show all 2 Pubmed References
Cow (Bovine) Polyclonal GLN1 Primary Antibody für IHC, WB - ABIN188921
Chakravarthy, Beli, Navitskaya, OReilly, Wang, Kady, Huang, Grant, Busik: Imbalances in Mobilization and Activation of Pro-Inflammatory and Vascular Reparative Bone Marrow-Derived Cells in Diabetic Retinopathy. in PLoS ONE 2016
Human Polyclonal GLN1 Primary Antibody für ICC, IF - ABIN4314691
Stadler, Rexhepaj, Singan, Murphy, Pepperkok, Uhlén, Simpson, Lundberg: Immunofluorescence and fluorescent-protein tagging show high correlation for protein localization in mammalian cells. in Nature methods 2013
Data show that 1,25-dihydroxyvitamin D (1,25D) downregulation of glutamine synthetase (GLUL (zeige GLUL Antikörper); GS)) was sufficient to reduce abundance and enzyme activity of GS.
genome-wide association study to identify genetic factors for familial hepatitis B virus-related hepatocellular carcinoma; results identified 2 large effect susceptible haplotypes located at GLUL (zeige GLUL Antikörper) and SLC13A2 (zeige SLC13A2 Antikörper)/FOXN1 (zeige FOXN1 Antikörper)
GLUL (zeige GLUL Antikörper) knockdown markedly inhibited the p38 MAPK (zeige MAPK14 Antikörper) and ERK1 (zeige MAPK3 Antikörper)/ERK2 (zeige MAPK1 Antikörper) signaling pathways in cultured breast cancer cells and reduces their proliferation.
co-targeting glutamine synthetase (zeige GLUL Antikörper) in stroma and glutaminase (zeige GLS Antikörper) in cancer cells reduces tumor weight, nodules, and metastasis.
This study demonstrated that Influence of glutamine synthetase (zeige GLUL Antikörper) gene polymorphisms on the development of hyperammonemia during valproic acid-based therapy.
GS is acetylated at lysines 11 and 14, yielding a degron that is necessary and sufficient for binding and ubiquitylation by CRL4(CRBN (zeige CRBN Antikörper)) and degradation by the proteasome.
Studied molecular mechanisms of glutamine synthetase (zeige GLUL Antikörper) mutations that lead to clinically relevant pathologies.
GLUL (zeige GLUL Antikörper) rs10911021 is associated prospectively with adjudicated cardiovascular composite end points among overweight/obese individuals with type 2 diabetes.
Data show that glutamine synthetase (GS (zeige GLUL Antikörper)) produces glutamine (zeige GFPT1 Antikörper) (Gln) from tricarboxylic acid (TCA)-cycle-derived carbons.
Data indicate that the triple stain of reticulin, glypican-3 (zeige GPC3 Antikörper), and glutamine (zeige GFPT1 Antikörper) synthetae is useful in the differentiation of hepatocellular carcinoma, hepatic adenoma, and focal nodular hyperplasia.
This study concludes that hepatic expression of alanine transaminase and glutathione synthetase (GS (zeige GSS Antikörper)) are reduced in aged cows, and administration of 17beta-estradiol increases plasma estradiol and hepatic GS.
Data show that glutamine synthetase (GS (zeige GLUL Antikörper))protein was preferentially expressed in hepatocytes adjacent to oxygen-supplying capillaries and in previously CPS-positive hepatocytes.
Diabetes induces TXNIP (zeige TXNIP Antikörper) expressions at mRNA levels, but shows the opposite effect on GS.
Results indicate that astrocyte glutamine synthase may be the predominant contributor to the pathogenic mechanisms of D-gal (zeige GAL Antikörper)-induced brain aging in mice.
Hepatic deletion of GS triggered systemic hyperammonemia, which was associated with cerebral oxidative stress as indicated by increased levels of oxidized RNA and enhanced protein Tyr (zeige TYR Antikörper) nitration.
modulation of intracellular glutamine (zeige GFPT1 Antikörper) levels by GS expression represents an endogenous mechanism through which mature adipocytes control the inflammatory response
GABABR2 (zeige GABBR2 Antikörper) has a role as a regulator of glutamine synthetase (zeige GLUL Antikörper) stability
the capacity for ammonia disposal correlated inversely with the expression of glutamine synthetase (zeige GLUL Antikörper) in muscle
Glutamine synthetase (zeige GLUL Antikörper) in astrocytes from entorhinal cortex of the triple transgenic animal model of Alzheimer's disease is not affected by pathological disease progression.
Renal glutamine synthetase (zeige GLUL Antikörper) is expressed in type A intercalated cells, non-A, non-B intercalated cells, and distal convoluted tubule cells, but not in principal cells, type B intercalated cells, or connecting segment cells.
Methionine sulfoximine target glutamine synthetase (zeige GLUL Antikörper) is required for the early steps of the cytokine response to endotoxins, and that its pharmacological inhibition may be exploited to treat inflammation.
BDNF (zeige BDNF Antikörper) can up-regulate GLAST (zeige SLC1A3 Antikörper) and GS and increase glutamate (zeige GRIN1 Antikörper) uptake during hypoxia, and these functions may underlie its neuroprotective effects.
The protein encoded by this gene belongs to the glutamine synthetase family. It catalyzes the synthesis of glutamine from glutamate and ammonia. Glutamine is a main source of energy and is involved in cell proliferation, inhibition of apoptosis, and cell signaling. This gene is expressed during early fetal stages, and plays an important role in controlling body pH by removing ammonia from circulation. Mutations in this gene are associated with congenital glutamine deficiency. Several alternatively spliced transcript variants have been found for this gene.
cell proliferation-inducing protein 59
, glutamate decarboxylase
, glutamate--ammonia ligase
, glutamine synthase
, glutamine synthetase
, proliferation-inducing protein 43
, glutamate-ammonia ligase (glutamine synthase)
, glutamate-ammonia ligase (glutamine synthetase)
, Glutamine synthetase (glutamate-ammonia ligase)
, glutamine synthetase 1